Sensus Healthcare, Inc. (SRTS)
| Market Cap | 64.37M -15.0% |
| Revenue (ttm) | 27.48M -34.3% |
| Net Income | -7.72M |
| EPS | -0.47 |
| Shares Out | 16.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,013 |
| Open | 3.976 |
| Previous Close | 3.960 |
| Day's Range | 3.895 - 4.055 |
| 52-Week Range | 3.030 - 5.920 |
| Beta | 1.19 |
| Analysts | Strong Buy |
| Price Target | 7.00 (+79.03%) |
| Earnings Date | May 7, 2026 |
About SRTS
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 V... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for SRTS stock is "Strong Buy." The 12-month stock price target is $7.0, which is an increase of 79.03% from the latest price.
News
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological...
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Earnings Call Transcript: Q4 2025
Exclusive CPT codes for SRT and IG-SRT provide reimbursement clarity, supporting broader adoption and international growth. 2025 saw lower revenues and a net loss, but a strong balance sheet and diversified customer base position the company for profitability in 2026.
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea...
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Earnings Call Transcript: Q3 2025
Q3 2025 saw revenue and unit sales decline year-over-year, but new CMS reimbursement codes for SRT are expected to drive strong future demand and improve ROI for dermatology practices. The company maintains a strong cash position, anticipates international growth, and expects to reach break-even or profitability in Q4.
Sensus Healthcare Reports Third Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for ...
Sensus Healthcare Named to TIME's America's Growth Leaders of 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare Announces the Passing of Director Bill McCall
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea...
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sensus (SRTS) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare's SRT Combined with Punch Excision to Treat Keloids
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $SRTS--SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm.
Sensus Healthcare Earnings Call Transcript: Q2 2025
Q2 2025 saw a revenue decline due to paused domestic sales amid reimbursement uncertainty, but international demand grew and recurring revenue partially offset lower capital sales. Management expects resolution of reimbursement issues by year-end, with strong cash reserves and new market opportunities ahead.
Sensus Healthcare Reports Second Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea...
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
Receipt of MDSAP Certification for Sensus Healthcare's Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective trea...